QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
- 16 November 2020Portfolio NewsCentauri Health Solutions Adds Referral Management and Analytics Capabilities with Acquisition of Ivy Ventures, LLC
- 16 November 2020Portfolio NewsCerevance’s CVN058 Achieves Primary Endpoint in Phase 1b Schizophrenia Cognition Study
- 12 November 2020Portfolio NewsNitrome Biosciences Announces Formation of Scientific Advisory Board and Appointment of Former AbbVie Executive James Summers, Ph.D. to SAB Chairperson
- 10 November 2020Portfolio NewsXilio Therapeutics to Present Data on Tumor-Selective Immunotherapies at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
- 10 November 2020SV NewsKate Bingham writes the foreword for Movers and Shakers in BioBusiness 2020
- 5 November 2020Portfolio NewsSaint Thomas and Urgent Team partner to expand affordable health services, create new patient entry points
- 29 October 2020Portfolio NewsComprehensive At-Home Treatment and Coaching Solution for Chronic Skin Conditions Rebrands as Zerigo Health
- 14 October 2020Portfolio NewsHealthify Partners with Altruista Health to Help Payors Address SDoH
- 1 October 2020Portfolio NewsNordic acquires Tasman Global
- 29 September 2020SV NewsSV Health Investors Announces the Appointment of Megan MacDonagh
- 29 September 2020Portfolio NewsAlchemab partners with Amii to accelerate the development of novel therapeutics to cure disease
- 28 September 2020Portfolio NewsAVROBIO Receives Orphan Drug Designation from the European Medicines Agency for AVR-RD-02, an Investigational Gene Therapy for Gaucher Disease